Mural Oncology PLC (MURA)

Currency in USD
1.590
-0.090(-5.36%)
Closed·
After Hours
1.630+0.040(+2.52%)
·
MURA Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual trading volume
MURA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.5701.680
52 wk Range
0.9504.740
Key Statistics
Prev. Close
1.68
Open
1.63
Day's Range
1.57-1.68
52 wk Range
0.95-4.74
Volume
643.22K
Average Volume (3m)
145.55K
1-Year Change
-51.38%
Book Value / Share
3.4
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MURA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
6.000
Upside
+277.36%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

Mural Oncology PLC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Mural Oncology PLC Company Profile

Mural Oncology plc operates as a clinical-stage oncology company that focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company’s lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops nemvaleukin to treat cutaneous melanoma and advanced solid tumors. The company also develops engineered interleukin-18 and tumor-targeted interleukin-12 programs. Mural Oncology plc was incorporated in 2017 and is based in Dublin, Ireland.

Compare MURA to Peers and Sector

Metrics to compare
MURA
Peers
Sector
Relationship
P/E Ratio
−0.2x−5.2x−0.5x
PEG Ratio
−0.010.030.00
Price/Book
0.5x4.8x2.6x
Price / LTM Sales
-9.5x3.3x
Upside (Analyst Target)
277.4%161.6%43.5%
Fair Value Upside
Unlock0.4%6.8%Unlock

Analyst Ratings

1 Buy
2 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 6.000
(+277.36% Upside)

Earnings

Latest Release
Aug 04, 2025
EPS / Forecast
-2.78 / -1.10
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

MURA Income Statement

People Also Watch

247.45
AVAV
-4.68%
5.29
REPL
-3.47%
9.070
CAPR
+12.39%
18.23
SRPT
+1.50%
2.9000
SNGX
-11.85%

FAQ

What Stock Exchange Does Mural Oncology Trade On?

Mural Oncology is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Mural Oncology?

The stock symbol for Mural Oncology is "MURA."

What Is the Mural Oncology Market Cap?

As of today, Mural Oncology market cap is 27.55M.

What Is Mural Oncology's Earnings Per Share (TTM)?

The Mural Oncology EPS (TTM) is -8.59.

When Is the Next Mural Oncology Earnings Date?

Mural Oncology will release its next earnings report on 11 Nov 2025.

From a Technical Analysis Perspective, Is MURA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Mural Oncology Stock Split?

Mural Oncology has split 0 times.

How Many Employees Does Mural Oncology Have?

Mural Oncology has 116 employees.

What is the current trading status of Mural Oncology (MURA)?

As of 09 Aug 2025, Mural Oncology (MURA) is trading at a price of 1.59, with a previous close of 1.68. The stock has fluctuated within a day range of 1.57 to 1.68, while its 52-week range spans from 0.95 to 4.74.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.